Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Flier

Showing results (201-210 of 791) with videos related to

Pageof 80
Sort By:
Current Medical Research and Opinion|August 5, 2008
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE studyC Ballard, M Sauter, P Scheltens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 27, 2014
Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinicFlora H Duits, Niels D Prins, Afina W Lemstra, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE projectMarleen Kunneman, Ruth Pel-Littel, Femke H Bouwman, et al.
Neurology|October 28, 2009
CSF biomarkers predict rate of cognitive decline in Alzheimer diseaseM I Kester, A E van der Vlies, M A Blankenstein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 25, 2005
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's diseaseL A van de Pol, A Hensel, W M van der Flier, et al.
Neurobiology of Aging|November 8, 2017
Gray matter network measures are associated with cognitive decline in mild cognitive impairmentEllen Dicks, Betty M Tijms, Mara Ten Kate, et al.
Alzheimer'S Research & Therapy|September 2, 2019
ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinicsAgnetha D Fruijtier, Leonie N C Visser, Ingrid S van Maurik, et al.
Journal of Alzheimer'S Disease : JAD|October 30, 2014
Serum leptin is not altered nor related to cognitive decline in Alzheimer's diseaseCharlotte E Teunissen, Wiesje M van der Flier, Philip Scheltens, et al.
Alzheimer'S Research & Therapy|April 15, 2023
Steeper memory decline after COVID-19 lockdown measuresEls D Bakker, Stéphanie L van der Pas, Marissa D Zwan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMiriam Rabl, Pyry Helkkula, Willem Lucas Hartog, et al.
Pageof 80

Showing results (201-210 of 791) with videos related to

Sort By:
Pageof 80
Current Medical Research and Opinion|August 5, 2008
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE studyC Ballard, M Sauter, P Scheltens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 27, 2014
Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinicFlora H Duits, Niels D Prins, Afina W Lemstra, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE projectMarleen Kunneman, Ruth Pel-Littel, Femke H Bouwman, et al.
Neurology|October 28, 2009
CSF biomarkers predict rate of cognitive decline in Alzheimer diseaseM I Kester, A E van der Vlies, M A Blankenstein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 25, 2005
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's diseaseL A van de Pol, A Hensel, W M van der Flier, et al.
Neurobiology of Aging|November 8, 2017
Gray matter network measures are associated with cognitive decline in mild cognitive impairmentEllen Dicks, Betty M Tijms, Mara Ten Kate, et al.
Alzheimer'S Research & Therapy|September 2, 2019
ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinicsAgnetha D Fruijtier, Leonie N C Visser, Ingrid S van Maurik, et al.
Journal of Alzheimer'S Disease : JAD|October 30, 2014
Serum leptin is not altered nor related to cognitive decline in Alzheimer's diseaseCharlotte E Teunissen, Wiesje M van der Flier, Philip Scheltens, et al.
Alzheimer'S Research & Therapy|April 15, 2023
Steeper memory decline after COVID-19 lockdown measuresEls D Bakker, Stéphanie L van der Pas, Marissa D Zwan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMiriam Rabl, Pyry Helkkula, Willem Lucas Hartog, et al.
Pageof 80